Are These 3 Stocks Going Higher?

CORAL GABLES, FL / ACCESSWIRE / August 16, 2017 / Stocks opened higher on Wednesday ahead of the pending Federal Reserve minutes. Later today around 2PM the Fed will meet, which will give investors some insight on what the future holds for interest rate hikes before the end of the year. In the July 25-26 meeting, policy makers unanimously determined to keep rates unchanged. This was in addition to planning on a reduction of the central bank’s holdings of bonds “relatively soon.” These include GT Biopharma Inc. (OXIS), Digiliti Money, Inc. (NASDAQ: DGLT), and Westport Fuel Systems Inc. (WPRT).

GT Biopharma Inc. (OXIS), is set to hold a conference call that will be hosted by BiotechStocks.com after the market close today 8/16/17 at 4:15PM EST. All interested parties can access the call via the following instructions:

Dial In #: 712-775-7031
Enter Meeting ID Number: 576-591-822

Over the course of the last few weeks, shares of (OXIS), have reached highs of $0.123 from an August 1 opening price of $0.0237. (OXIS) Chairman and CEO Tony Cataldo stated in a recent press release, “There is a lot going on inside GT Biopharma (OXIS), and it is better to speak with our shareholders and market participants so everyone can understand what all of the excitement is about. Kathleen and I are pleased to make ourselves available to discuss the rationale of this merger.”

Digiliti Money, Inc. (NASDAQ: DGLT) has traded higher on Wednesday with some of its highest single day of share volume all year. Shares opened at $0.21 and have seen a high of $0.64 during the first hour and a half of the market being open. Digtliti is a leading cloud-based, SaaS technology provider for the now way to bank, serving the financial services industry with mobile money and remote deposit capture solutions for PC, Mac and mobile.

Earlier this week, that company said that it is considering strategic options to restructure the company, including a potential sale, or potentially filing for chapter 11 bankruptcy. Management stated, “The company believed it had the opportunity to obtain financing to fund its immediate cash needs, however after disclosing the situation to the potential funder, we believe the financing is no longer certain.”

Westport Fuel Systems Inc. (WPRT) remains in its two-week uptrend. On August 2, shares traded as low as $1.53 but by Wednesday, August 16, shares of Westport have seen highs of $2.39. This represent a move in share price of 56%. After reporting earnings this week, results beat Wall Street expectations. The maker of natural-gas engine technology posted revenue of $62.1 million in the period.

“In the first year of the new leadership team, we have achieved $30 million of run-rate merger cost savings a year ahead of schedule; have sold non-core assets generating in excess of $100 million in cash; have improved Q2 2017 adjusted EBITDA by 54% compared to the same period last year; and are on track for the launch of the Westport High Pressure Direct Injection 2.0,” stated CEO Nancy Gougarty in the company’s earnings release. On August 14th.

For free up to the minute financial news updates, text keyword BIOTECH to 474747.

About BiotechStocks.com

BiotechStocks.com (“BTS”) is owned by MIDAM Ventures, LLC., a Florida corporation. BTS produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. BTS has been compensated: via, MIDAM VENTURES LLC, in the amount of $150,000 by a non-affiliate 3rd party for a period beginning 8/8/2017 and ending 9/7/2017 to publicly disseminate information about MEDD. We own zero shares.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither BTS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.BiotechStocks.com/.

NO WARRANTY

BTS, the Author, and the Reviewer (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect, or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

Contact:

news@biotechstocks.com

SOURCE: BiotechStocks.com

ReleaseID: 472801